A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis
about
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of HaitiAntibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA)Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infectionCT694 and pgp3 as serological tools for monitoring trachoma programsTransmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluationSerology for trachoma surveillance after cessation of mass drug administrationElimination of lymphatic filariasis in the GambiaA comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administrationSeroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administrationElectronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based systemBayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administrationApplication of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India.Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.The use of bivariate spatial modeling of questionnaire and parasitology data to predict the distribution of Schistosoma haematobium in Coastal Kenya.Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo.Detection of Wuchereria bancrofti DNA in paired serum and urine samples using polymerase chain reaction-based systems.A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration.Surgical Treatment of Genital Manifestations of Lymphatic Filariasis: A Systematic Review.Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination programLymphatic filariasis in Brazil: epidemiological situation and outlook for eliminationMonitoring and evaluation of lymphatic filariasis interventions: an improved PCR-based pool screening method for high throughput Wuchereria bancrofti detection using dried blood spots.Evaluation of PCR-ELISA as a tool for monitoring transmission of Wuchereria bancrofti in District of Gampaha, Sri Lanka.Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable SpectrodensitometerA practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands.Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human bloodMathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.Insecticidal bed nets and filariasis transmission in Papua New Guinea.Relevance of the eosinophil blood count in bancroftian filariasis as a screening tool for the treatment.Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.Molecular identification and phylogenetic analysis of Wuchereria bancrofti from human blood samples in Egypt.Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration.Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection.Evaluation of diagnostic tests for Wuchereria bancrofti infection in Brazilian schoolchildren.Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana.Breast filariasis or inflammatory breast carcinoma? Reaching a diagnosis.A novel rapid test for detecting antibody responses to Loa loa infections.Evaluation of Multiplex-Based Antibody Testing for Use in Large-Scale Surveillance for Yaws: a Comparative Study.
P2860
Q27692876-869349C7-420B-4459-9A7F-B558D9BD6E1CQ28484230-6F6D3020-4005-40DE-ABAA-73236375C0A1Q28484232-62649FCE-473E-4897-B6B8-2FD81874718CQ28484234-A291990B-C9C3-427F-94C2-CC5DE12590D3Q28484816-4AB05629-81B1-41F2-B991-C7E6345AB5FDQ28536142-343DBC42-DBBB-4BCE-85CF-B8703E4B4945Q28543658-558B99CC-5EB0-49F8-AA86-159E5E7758EDQ28544640-5EAA5E96-58F8-48E4-A84B-D1536000EBCFQ28544914-9FA50B71-9C87-4665-B654-F574953CBE28Q28544925-ACE38308-494F-473C-BF9E-836393A631B9Q28660227-6A3B72FB-60E1-401C-8CB3-8FA68F974A5DQ30670492-248AE917-A282-49CD-95D3-E0588525259AQ33593052-F99E1914-F4E6-4E67-9A0B-6546BDDE1DB2Q33602799-A7ADA546-D234-4835-A719-124844B0784BQ33752085-4C0DFD12-E6FB-4A55-BFB9-37649B250A57Q34566637-8E1FF263-3B97-483B-9348-AC6387F2311BQ34640167-AD4A7A26-9B3A-4D56-A38E-61AB4D1C744CQ35076420-822E5C17-A5C7-445D-B927-692E50F4299DQ35689798-6BEE02F0-681F-4415-A665-F3D50766030CQ35759590-109A8361-4D64-4493-9A11-490EB1415325Q35795540-C374E2F1-69DC-460A-AD11-7419794687C0Q36535035-A63DAE05-EE70-4EB7-9C37-353C9E058B04Q36797715-E6A3E199-DCB7-4FC2-8C62-4890C41B30FBQ36812628-3D2E90E7-E348-43C3-936A-7D37A2A674CCQ36958528-E6BEB2C2-AFC6-44D5-8B19-D08F9FCCED4EQ37053364-3C1B578F-1E08-4CA1-AED1-E2724F98CC27Q37107904-ECB2A7BF-2B36-408D-A94F-A5FC29DC0AAAQ37254795-378AB337-858E-4C03-B3B1-8A1C7E53F91CQ37287695-FB4D60D7-0700-4330-A416-2723A8444AD0Q37329115-F44C18DB-B47B-49E7-B6C7-823D96C299AAQ37726538-D66060C4-53DA-4D57-B58B-15474A114588Q38123552-4A509156-BB05-45E6-B4C8-F482C0A35F44Q38855348-1D99D61F-F8A2-4D12-B06B-EBE38D46D51AQ38955116-8630AC1C-CA9B-469A-99FF-84222C5E6F02Q39095216-DA3EB577-99A8-4C15-B906-FAD04C62B80EQ39322274-C69F8888-8D62-493D-A9E1-0F0AD5D08DA7Q39331840-B1352BED-80C7-4CE6-AA99-79A54465C632Q39335749-9B35B5D2-0BF6-49C3-9D88-5C079BFB3790Q39346014-3D449ED5-F14D-4B73-B69E-91466818F268Q39932870-BA61BC30-3BBB-451B-BC9A-E607FC0D39DE
P2860
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A multicenter evaluation of di ...... iminate bancroftian filariasis
@ast
A multicenter evaluation of di ...... iminate bancroftian filariasis
@en
A multicenter evaluation of di ...... iminate bancroftian filariasis
@nl
type
label
A multicenter evaluation of di ...... iminate bancroftian filariasis
@ast
A multicenter evaluation of di ...... iminate bancroftian filariasis
@en
A multicenter evaluation of di ...... iminate bancroftian filariasis
@nl
prefLabel
A multicenter evaluation of di ...... iminate bancroftian filariasis
@ast
A multicenter evaluation of di ...... iminate bancroftian filariasis
@en
A multicenter evaluation of di ...... iminate bancroftian filariasis
@nl
P2093
P2860
P50
P921
P3181
P1476
A multicenter evaluation of di ...... iminate bancroftian filariasis
@en
P2093
Anne-Marie Legrand
Catherine Plichart
Dominique Kyelem
Eric A Ottesen
Gary J Weil
Hayley Joseph
Jeffrey Talbot
John Gyapong
Kapa Ramaiah
Katherine Gass
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0001479
P407
P5008
P577
2012-01-01T00:00:00Z